Literature DB >> 6265362

Influence of yeast mannan on human neutrophil functions: inhibition of release of myeloperoxidase related to carbohydrate-binding property of the enzyme.

C D Wright, M J Herron, G R Gray, B Holmes, R D Nelson.   

Abstract

We investigated the possibility that dissolved mannan polysaccharide from Candida may have an inhibitory influence on the host defense mechanisms associated with neutrophils and thereby contribute to the pathogenesis of candidoses. We created a model for this hypothesis by using mannan derived from bakers' yeast (Saccharomyces cerevisiae) and mannan isolated from the serum of a patient with chronic mucocutaneous candidosis. We observed that these mannans inhibited the respiratory burst and release of myeloperoxidase stimulated by phagocytosis of serum-opsonized zymosan in vitro. Mannan did not inhibit release of three other lysosomal enzymes. The selective inhibition of release of myeloperoxidase was attributable to a carbohydrate-binding property of the enzyme, with the mannan causing co-sedimentation of the enzyme with the cellular fraction.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6265362      PMCID: PMC351508          DOI: 10.1128/iai.32.2.731-738.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

1.  Myeloperoxidase: confirmation and nature of heme-binding inequivalence. Resolution of a carbonyl-substituted heme.

Authors:  J E Harrison; J Schultz
Journal:  Biochim Biophys Acta       Date:  1978-10-23

2.  Recognition and receptor-mediated uptake of a lysosomal enzyme, alpha-l-iduronidase, by cultured human fibroblasts.

Authors:  G N Sando; E F Neufeld
Journal:  Cell       Date:  1977-11       Impact factor: 41.582

3.  Infectious complications in renal transplant recipients.

Authors:  T C Eickhoff
Journal:  Transplant Proc       Date:  1973-09       Impact factor: 1.066

4.  Character of azurophil and specific granules purified from human polymorphonuclear leukocytes.

Authors:  J K Spitznagel; F G Dalldorf; M S Leffell; J D Folds; I R Welsh; M H Cooney; L E Martin
Journal:  Lab Invest       Date:  1974-06       Impact factor: 5.662

5.  Fungal infections complicating acute leukemia.

Authors:  G P Bodey
Journal:  J Chronic Dis       Date:  1966-06

6.  A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

7.  Effect of phorbol myristate acetate on the oxidative metabolism of human polymorphonuclear leukocytes.

Authors:  L R DeChatelet; P S Shirley; R B Johnston
Journal:  Blood       Date:  1976-04       Impact factor: 22.113

8.  Separation and characterization of human neutrophil granules.

Authors:  B C West; A S Rosenthal; N A Gelb; H R Kimball
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

9.  The properdin system and immunity. V. The bactericidal activity of the properdin system.

Authors:  A C WARDLAW; L PILLEMER
Journal:  J Exp Med       Date:  1956-05-01       Impact factor: 14.307

10.  Alteration of polymorphonuclear leukocyte activity by viable Candida albicans.

Authors:  A E Hilger; D L Danley
Journal:  Infect Immun       Date:  1980-03       Impact factor: 3.441

View more
  13 in total

1.  Mannan as an antigen in cell-mediated immunity (CMI) assays and as a modulator of mannan-specific CMI.

Authors:  J E Domer; R E Garner; R N Befidi-Mengue
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

2.  Purification and characterization of the serotype c antigen from Actinobacillus actinomycetemcomitans.

Authors:  J J Zambon; J Slots; K Miyasaki; R Linzer; R Cohen; M Levine; R J Genco
Journal:  Infect Immun       Date:  1984-04       Impact factor: 3.441

3.  Enhancement of non-Candida antibody responses by Candida albicans cell wall glycoprotein.

Authors:  J E Domer; K L Elkins; D L Ennist; P W Stashak; R E Garner; P J Baker
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

4.  Role of high-avidity binding of human neutrophil myeloperoxidase in the killing of Actinobacillus actinomycetemcomitans.

Authors:  K T Miyasaki; J J Zambon; C A Jones; M E Wilson
Journal:  Infect Immun       Date:  1987-05       Impact factor: 3.441

5.  Hypochlorite scavenging by Pseudomonas aeruginosa alginate.

Authors:  D B Learn; E P Brestel; S Seetharama
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

6.  Candidacidal activity of myeloperoxidase: therapeutic influence of the enzyme in vivo.

Authors:  C D Wright; R D Nelson
Journal:  Infect Immun       Date:  1985-02       Impact factor: 3.441

7.  Differential regulation of the activation of human eosinophils, macrophages, and neutrophils: effect of the allergic mediator release inhibitor CI-949.

Authors:  C D Wright; L J Devall; D O Aker; D O Thueson; M C Conroy
Journal:  Agents Actions       Date:  1990-08

8.  Differential regulation of human eosinophil, macrophage, and neutrophil functions by the allergic mediator release inhibitor CI-959.

Authors:  C D Wright; L J Devall; K A Aker; D O Thueson; M C Conroy
Journal:  Agents Actions       Date:  1992-05

9.  Immunodominant antigen of Actinobacillus actinomycetemcomitans Y4 in high-responder patients.

Authors:  J V Califano; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

10.  Candidacidal activity of myeloperoxidase: mechanisms of inhibitory influence of soluble cell wall mannan.

Authors:  C D Wright; J U Bowie; G R Gray; R D Nelson
Journal:  Infect Immun       Date:  1983-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.